scispace - formally typeset
Search or ask a question
Institution

Technion – Israel Institute of Technology

EducationHaifa, Israel
About: Technion – Israel Institute of Technology is a education organization based out in Haifa, Israel. It is known for research contribution in the topics: Population & Upper and lower bounds. The organization has 31714 authors who have published 79377 publications receiving 2603976 citations. The organization is also known as: Technion Israel Institute of Technology & Ṭekhniyon, Makhon ṭekhnologi le-Yiśraʼel.


Papers
More filters
Journal ArticleDOI
TL;DR: A computer vision approach that removes degradation effects in underwater vision is presented, which inverts the image formation process for recovering good visibility in images of scenes and analyzes the noise sensitivity of the recovery.
Abstract: Underwater imaging is important for scientific research and technology as well as for popular activities, yet it is plagued by poor visibility conditions. In this paper, we present a computer vision approach that removes degradation effects in underwater vision. We analyze the physical effects of visibility degradation. It is shown that the main degradation effects can be associated with partial polarization of light. Then, an algorithm is presented, which inverts the image formation process for recovering good visibility in images of scenes. The algorithm is based on a couple of images taken through a polarizer at different orientations. As a by-product, a distance map of the scene is also derived. In addition, this paper analyzes the noise sensitivity of the recovery. We successfully demonstrated our approach in experiments conducted in the sea. Great improvements of scene contrast and color correction were obtained, nearly doubling the underwater visibility range.

492 citations

Journal ArticleDOI
27 Aug 2021-Science
TL;DR: In this article, the authors discuss current evidence regarding the transmission of respiratory viruses by aerosols-how they are generated, transported, and deposited, as well as the factors affecting the relative contributions of droplet-spray deposition versus aerosol inhalation as modes of transmission.
Abstract: The COVID-19 pandemic has revealed critical knowledge gaps in our understanding of and a need to update the traditional view of transmission pathways for respiratory viruses. The long-standing definitions of droplet and airborne transmission do not account for the mechanisms by which virus-laden respiratory droplets and aerosols travel through the air and lead to infection. In this Review, we discuss current evidence regarding the transmission of respiratory viruses by aerosols-how they are generated, transported, and deposited, as well as the factors affecting the relative contributions of droplet-spray deposition versus aerosol inhalation as modes of transmission. Improved understanding of aerosol transmission brought about by studies of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection requires a reevaluation of the major transmission pathways for other respiratory viruses, which will allow better-informed controls to reduce airborne transmission.

492 citations

Journal ArticleDOI
TL;DR: Aliment Pharmacol Ther 2011; 33: 987–995.
Abstract: Aliment Pharmacol Ther 2011; 33: 987–995 Summary Background Loss of response to anti-TNF agents in Crohn’s disease is an emerging clinical problem. Aim To review the causes, incidence and management approach of loss of response. Methods A search of medical database (PubMed) and of meetings’ proceedings for definitions, causes and incidence of loss of response was carried out. Personal correspondence with principal investigators was conducted to retrieve missing data. Results Various definitions of loss of response abound, hampering the ability to assess accurately the magnitude and management of this clinical problem. We propose to distinguish between a clinical worsening on anti-TNF treatment and a true loss of response to anti-TNFs. Accordingly, loss of response to anti-TNFs at 12 months of therapy occurs in 23–46% of patients when judged by dose intensification, or 5–13% when gauged by drug discontinuation rates. The management of loss of response should allow for a period of watchful waiting as quite often the patients’ symptoms may resolve without alteration of therapy. If they do not, then identifying the correct mechanism responsible for clinical deterioration is prudent. Once symptoms are ascertained to arise from inflammatory IBD activity, drug level and antidrug antibody measurement can then help distinguish between non-adherence to therapy, immunogenicity and non-immune clearance of anti-TNF, or an un-chequered inflammation despite adequate anti-TNF levels. The latter finding may be best addressed by a switch to another class of immunomodulators, whereas a low drug level should probably be managed by dose intensification or a switch to another anti-TNF. Conclusion Studies defining how best to translate drug-level monitoring and other mechanistic considerations into clinical decisions are urgently needed.

491 citations

Journal ArticleDOI
TL;DR: A review of the Quasicontinuum method, from its original motivations and formulation to recent improvements and developments, and a summary of the important mechanics of materials results that have been obtained using the QC approach is presented.
Abstract: The Quasicontinuum (QC) Method, originally conceived and developed by Tadmor, Ortiz and Phillips [1] in 1996, has since seen a great deal of development and application by a number of researchers The idea of the method is a relatively simple one With the goal of modeling an atomistic system without explicitly treating every atom in the problem, the QC provides a framework whereby degrees of freedom are judiciously eliminated and force/energy calculations are expedited This is combined with adaptive model refinement to ensure that full atomistic detail is retained in regions of the problem where it is required while continuum assumptions reduce the computational demand elsewhere This article provides a review of the method, from its original motivations and formulation to recent improvements and developments A summary of the important mechanics of materials results that have been obtained using the QC approach is presented Finally, several related modeling techniques from the literature are briefly discussed As an accompaniment to this paper, a website designed to serve as a clearinghouse for information on the QC method has been established at wwwqcmethodcom The site includes information on QC research, links to researchers, downloadable QC code and documentation

491 citations

Journal ArticleDOI
TL;DR: These nanoparticles mediate the most durable non-liver silencing reported so far and facilitate the delivery of siRNAs that modify endothelial function in mouse models of vascular permeability, emphysema, primary tumour growth and metastasis.
Abstract: Dysfunctional endothelium contributes to more diseases than any other tissue in the body. Small interfering RNAs (siRNAs) can help in the study and treatment of endothelial cells in vivo by durably silencing multiple genes simultaneously, but efficient siRNA delivery has so far remained challenging. Here, we show that polymeric nanoparticles made of low-molecular-weight polyamines and lipids can deliver siRNA to endothelial cells with high efficiency, thereby facilitating the simultaneous silencing of multiple endothelial genes in vivo. Unlike lipid or lipid-like nanoparticles, this formulation does not significantly reduce gene expression in hepatocytes or immune cells even at the dosage necessary for endothelial gene silencing. These nanoparticles mediate the most durable non-liver silencing reported so far and facilitate the delivery of siRNAs that modify endothelial function in mouse models of vascular permeability, emphysema, primary tumour growth and metastasis. Polymeric nanoparticles can efficiently deliver siRNAs to endothelial cells in vivo and silence multiple genes for weeks.

490 citations


Authors

Showing all 31937 results

NameH-indexPapersCitations
Robert Langer2812324326306
Nicholas G. Martin1921770161952
Tobin J. Marks1591621111604
Grant W. Montgomery157926108118
David Eisenberg156697112460
David J. Mooney15669594172
Dirk Inzé14964774468
Jerrold M. Olefsky14359577356
Joseph J.Y. Sung142124092035
Deborah Estrin135562106177
Bruce Yabsley133119184889
Jerry W. Shay13363974774
Richard N. Bergman13047791718
Shlomit Tarem129130686919
Allen Mincer129104080059
Network Information
Related Institutions (5)
Imperial College London
209.1K papers, 9.3M citations

93% related

Massachusetts Institute of Technology
268K papers, 18.2M citations

92% related

University of Illinois at Urbana–Champaign
225.1K papers, 10.1M citations

92% related

Stanford University
320.3K papers, 21.8M citations

92% related

University of Toronto
294.9K papers, 13.5M citations

92% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
2023147
2022390
20213,397
20203,526
20193,273
20183,131